Chinese Journal of Tissue Engineering Research ›› 2015, Vol. 19 ›› Issue (28): 4455-4459.doi: 10.3969/j.issn.2095-4344.2015.28.006

Previous Articles     Next Articles

Biocompatibility of bio-derived xenograft bone with bone marrow mesenchymal stem cells

Gao Ming-jie, Tao Jie, Zhou Zi-hui, Du Lin   

  1. Department of Orthopedics, Shanghai General Hospital, Shanghai Jiao Tong University, Shanghai 200080, China
  • Online:2015-07-02 Published:2015-07-02
  • Contact: Tao Jie, M.D., Chief physician, Professor, Master’s supervisor, Department of Orthopedics, Shanghai General Hospital, Shanghai Jiao Tong University, Shanghai 200080, China
  • About author:Gao Ming-jie, Master, Department of Orthopedics, Shanghai General Hospital, Shanghai Jiao Tong University, Shanghai 200080, China
  • Supported by:

     the Key Project of Shanghai Science and Technology Committee, No. 12441902402

Abstract:

BACKGROUND: Bio-derived xenograft bone has natural pore structure of the bone, low immunogenicity, and good cytocompatibility.

OBJECTIVE: To verify the biocompatibility of bio-derived xenograft bone with bone marrow mesenchymal stem cells.
METHODS: Fresh pig femoral bone was collected to prepare bio-derived bone. Scanning electron microscope was used to observe the material structure. Passage 3 rabbit bone marrow mesenchymal stem cells at a density of 2×109/L were inoculated into the cancellous bone surface of the bio-dervied bone and cultured for 7 days. Cell growth was detected using scanning electron microscope. After culture for 8 days, cell number was counted.

RESULTS AND CONCLUSION: The bio-derived bone had rough surface and irregularly interconnected pores constructing a mesh-like structure. After 3 days of compound culture, cells had irregular shapes and adhered to the surface of bio-derived bone; after 5 days of culture, cells were closely interconnected to form a layered growth; after 7 days of culture, cells exhibited multilayered growth and the extracellular matrix secreted locally. Under compound culture, the former 2 days were latent period, 3-6 days were logarithmic phase, and from the 6th day, the cell growth curve became smooth gradually and the cell proliferation decreased and entered into the plateau period. These findings indicate that the bio-derived xenograft bone has good biocompatibility with bone marrow mesenchymal stem cells.

中国组织工程研究杂志出版内容重点:干细胞;骨髓干细胞;造血干细胞;脂肪干细胞;肿瘤干细胞;胚胎干细胞;脐带脐血干细胞;干细胞诱导;干细胞分化;组织工程

Key words: Biocompatible Materials, Stem Cells, Bone Marrow

CLC Number: